Skip to Content is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in News for Health Professionals

Cannabidiol Studied as Potential Treatment for Cannabis Use Disorder

Abstinence from cannabis is increased with daily oral doses of cannabidiol 400 mg and 800 mg versus placebo, according to a dose-finding study published online July 28 in The Lancet Psychiatry. Tom P. Freeman, Ph.D., from University of Bath in the United Kingdom, and colleagues conducted a phase 2a randomized trial to identify efficacious doses of...

Posted today in Medical

Schools Can Reopen Safely If Precautions in Place, Australian Study Shows

Safeguards such as contact tracing and swift isolation of cases of COVID-19 could be the key to reopening U.S. schools safely this September, a study from Australia shows. In the study, which involved thousands of schools or preschools, a total of 27 kids or teachers were determined to have been present in schools while they were infected with the...

Posted today in Medical

November Election Can Be Held Safely, Experts Contend

With the 2020 presidential election just three months away, new research suggests an election can be held safely if stringent steps are taken to lower COVID-19 infection risk. The conclusion follows a U.S. Centers for Disease Control and Prevention investigation that looked at what happened in the city of Milwaukee this past April after Wisconsin became...

Posted 2 days ago in New Drug Approvals

FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

PLANEGG/MUNICH, Germany - August 1, 2020 and WILMINGTON, Del. - July 31, 2020 MorphoSys AG NASDAQ:MOR) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi (tafasitamab-cxix) in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell...

Posted today in Medical

Coronavirus Cases Now Climbing in the Midwest

Midwestern states are starting to see surges in coronavirus cases, just as Southern and Western states are scrambling to contain their own outbreaks of COVID-19. Missouri, Montana and Oklahoma are among those witnessing the largest percentage surge of infections over the past week, the Washington Post reported. At the same time, the number of new cases...

Posted today in Medical

Aggressive Cancer Diagnosed for First Time in a Dinosaur

Scientists for the first time have identified an aggressive bone cancer in a dinosaur that lived nearly 77 million years ago. The cancerous lower leg bone (fibula) is from a horned dinosaur called a Centrosaurus apertus. At first, researchers thought the bone had been broken and was healing when the animal died, but state-of-the-art technology showed...

Posted today in Medical

Many Older Americans Staying Strong in the Pandemic

Older Americans are feeling stressed by COVID-19 and prolonged social isolation, but they're also showing their resiliency, a new study finds. Most of these adults have turned to a range of tools to stay in touch, researchers report. "Many of the social venues that help older adults stay engaged are effectively cut off now with social distancing. While...

Posted today in Medical

Health Highlights: Aug. 4, 2020

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Medicare Should Expand Telehealth: Trump President Donald Trump signed an order on Monday that will broaden the role of telehealth for Medicare patients, the Associated Press reported. Although the executive order is limited to rural patients, the...

Posted today in News for Health Professionals

Cost-Related Rx Nonadherence Highest in Young U.S. Women

Cost-related prescription nonadherence is highest among younger U.S. women compared with individuals living in 10 other high-income countries, according to a report published in the August issue of Health Affairs. Jamie R. Daw, Ph.D., from the Columbia Mailman School of Public Health in New York City, and Michael R. Law, Ph.D., from University of British...

Posted today in News for Health Professionals

Vitamin D3 Does Not Reduce Depression Incidence, Recurrence

Treatment with vitamin D3 versus placebo does not result in a significant difference in the incidence and recurrence of depression or clinically relevant depressive symptoms or in a change in mood scores among adults aged 50 years or older without clinically relevant depressive symptoms, according to a study published in the Aug. 4 issue of the Journal...

Read more news...

Recently added consumer and prescribing information: Monjuvi, Tecartus, Xeglyze, Breztri Aerosphere, Inqovi, Rukobia, Qwo, Gimoti, Dojolvi, Mycapssa

Posted in Blog

Feeling the heat? Maybe your medication is to blame.

With the weather heating up across the U.S. it seems good timing that most states are easing their lockdown restrictions. Escaping into the sun is something we are all looking forward to, especially after a winter of confinement at home. But did you know that heat-related deaths are one of the deadliest weather-related outcomes in […]

Posted in Blog

Vitamin C: Time to take this supplement seriously?

Vitamin C has always been a controversial supplement. To some, it belongs firmly in the alternative medicine basket, with apparently no substantial evidence to support its use. To others, it holds promise, particularly if you are talking about certain groups of people who are likely to be low in vitamin C. Because we NEED vitamin […]

Posted in Blog

Medical Advances Amidst COVID-19 Chaos

Undeniably, we are in unprecedented times. COVID-19 is a serious and fatal disease for some and globally it has, and will continue to have, wide-reaching implications, medically, socially, and financially for some time. But medical advances will be significant. Although we have learned a lot about the new coronavirus already, there is still a lot […]

See more blog posts or follow us on twitter.